We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study.
- Authors
Santoro, Cristina; Fuh, Beng; Le, Phu Quoc; Maes, Philip; Berrueco, Rubén; Mingot‐Castellano, Eva Maria; von Mackensen, Sylvia; Solms, Alexander; Wang, Michael
- Abstract
Objectives: To report interim data from TAURUS, a study assessing real‐world prophylactic treatment with unmodified, full‐length recombinant FVIII BAY 81‐8973 (Kovaltry®; Bayer) indicated for haemophilia A. Methods: TAURUS (NCT02830477) is an international, open‐label, prospective, non‐interventional, single‐arm study with a one‐year observation period (target N = 350). Patients have moderate or severe haemophilia A (FVIII ≤5% or ≤1%) and ≥50 exposure days to any FVIII product. Clinician‐ and patient‐reported outcomes are captured on previous product use, changes in prophylaxis dose and dosing frequency, FVIII consumption, reported bleeding rates, treatment satisfaction and adherence, pharmacokinetic (PK) data (if available) and safety data. Results: At cut‐off, baseline data were available from 160 patients (89 had ≥6 months of follow‐up data). Most patients had severe haemophilia A (85%), infused BAY 81‐8973 ≥ 3×/wk (59%) and experienced a median number of total bleeds of 2.0 (non‐annualised; 246 days median documentation period). Good levels of treatment satisfaction (Hemo‐SATA,P) and adherence (VERITAS‐Pro) were maintained. TAURUS demonstrated a favourable PK profile of BAY 81‐8973 in comparison with other standard half‐life rFVIIIs and supported the WAPPS PopPK model. No patients developed inhibitors. Conclusions: TAURUS data demonstrate effective prophylaxis with BAY 81‐8973 in the real world without compromising patient satisfaction or adherence.
- Subjects
HEMOPHILIA; PHARMACOKINETICS; PATIENT compliance; PATIENT satisfaction; BAYS
- Publication
European Journal of Haematology, 2020, Vol 105, Issue 2, p164
- ISSN
0902-4441
- Publication type
Article
- DOI
10.1111/ejh.13420